Boryung Corporation (KRX:003850)

South Korea · Delayed Price · Currency is KRW

8,660.00

-110.00 (-1.25%)

Oct 8, 2026, 9:24 AM KST

Market Cap	728.53B +0.4%
Revenue (ttm)	1.06T +4.0%
Net Income	120.58B +279.2%
EPS	1,436.22 +249.8%
Shares Out	84.13M
PE Ratio	6.11
Forward PE	11.19
Dividend	160.00 (1.85%)
Ex-Dividend Date	Dec 29, 2025

Volume	4,471
Open	8,700.00
Previous Close	8,770.00
Day's Range	8,570.00 - 8,700.00
52-Week Range	7,410.00 - 10,800.00
Beta	0.33
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Boryung

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea. [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1957

Employees 1,533

Stock Exchange Korea Stock Exchange

Ticker Symbol 003850

Full Company Profile

Financial Performance

In 2025, Boryung's revenue was 1.02 trillion, an increase of 0.03% compared to the previous year's 1.02 trillion. Earnings were 64.30 billion, a decrease of -7.65%.

Financial Statements